Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Citycon has published its 2023 Sustainability Accounts featuring the company’s refined sustainability strategy

CITYCON OYJ Corporate Press Release 25 March 2024 at 9:30 Citycon Oyj’s 2023 Sustainability Accounts have been published today, reflecting the impact of its updated sustainability strategy. The highlights of the year include the transformation of some of our centres into robust transportation hubs with a strong emphasis on green mobility. The introduction of state-of-the-art technology, including AI, mark the company’s commitment to energy efficiency. An all-time-high of 1,100 community engagement initiatives across the centres is a testament of Citycon’s efforts in creating

Fayes Investeringar 1 AB publishes the offer document for the recommended public cash offer to the shareholders of Awardit AB (publ)

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States of America (the “US”), or any other jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law or

Cereno Scientific participates at the upcoming medical conference ACC.24 to further build presence in the Cardiology community

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for common and rare cardiovascular disease, today announced presence at ACC’s 73rd Annual Scientific Session & Expo (ACC.24) organized by the American College of Cardiology. The event is held between April 6–8, 2024 in Atlanta, Georgia, USA.“Participating at leading cardiology congresses, such as ACC.24, is an important aspect of our strategy to continue to raise awareness about our portfolio of innovative drug candidates, learn about the most recent advances and expand our network among

Notice of Annual General Meeting in Rejlers AB (publ)

The shareholders of Rejlers AB (publ), reg. no 556349-8426 (the “Company”), are hereby summoned to the Annual General Meeting on Thursday, 25 April 2024 at 04:00 p.m. at the Company’s office at Lindhagensgatan 126 in Stockholm, Sweden. Registration for the Meeting will commence at 03:30 p.m. Notification Shareholders who wish to participate in the Meeting must: i. both be recorded as shareholders in the share register kept by Euroclear Sweden AB on the record date on Wednesday, 17 April 2024; andii. no later than Friday, 19 April 2024 have notified their attendance and any

SKF joins new research and innovation project aiming to eliminate Greenhouse gas emissions

Gothenburg, 25 March 2024: SKF has decided to join and co-fund Mission 0 to contribute to the development of groundbreaking technologies and deliver solutions to eliminate greenhouse gas (GHG) emissions in materials, production and end-of-life of passenger cars. In an initial pilot project, SKF will collaborate with academia and industry experts in a research arena to solve GHG emissions in materials and processes that require new knowledge or disruptive technologies. ”In this deciding decade, we need to take the right decisive actions. At SKF, we are committed to sustainability, and we

Valmet to invest in filter fabric manufacturing in South America

Valmet Oyj’s trade press release on March 25, 2024 at 9:30 a.m. EETValmet has decided to invest in filter fabric manufacturing in Belo Horizonte, Brazil, in order to better respond to the growing demand of high-performing filter fabrics in both the mining and pulp and paper industries in South America. The value of the new investment will not be disclosed. “The investment includes the relocation of the current office and manufacturing facility in Belo Horizonte, new machinery, and improvements in the operations’ energy efficiency and emission reduction. It gives us the necessary assets

AFRY secures owner’s engineering assignment for large-scale solar power project in the Philippines

Aboitiz Solar Power, Inc., a subsidiary of Aboitiz Power Corporation (AboitizPower) has appointed AFRY as the owner’s engineer for the construction of a 172 MWp solar photovoltaic (PV) plant including grid interconnection works. The project, located in Negros Occidental in the Philippines, aims to feed renewable energy into the Visayas grid.AboitizPower is one of the biggest power companies in the Philippines and the Calatrava project is one of the five projects in its portfolio of solar power projects which has nearly 1,000 MW of renewable energy projects in the pipeline, with plans to

FTN announces award decision in the procurement of European equity funds

The Swedish Fund Selection Agency, FTN, has made an award decision in the first procurement for the premium pension fund platform. Six fund managers are awarded fund agreements.Today, March 25th, FTN publishes the award decision in the procurement of actively managed European equity funds large/mid cap. A total of six fund managers are awarded fund agreements for funds on the premium pension fund platform. These fund managers and funds are: +---------------------------------+----------------------------------------------+| Fondförvaltare | Fond

Transaction in Own Shares

[Bodycote] www.bodycote.com   25 March 2024   Bodycote plc   Share Buyback Programme - Transactions in Own Securities   Bodycote plc (the Company) announces that, in accordance with the terms of its share buyback programme announced on 15 March 2024 (the Programme) it has purchased the following number of its ordinary shares of 173/11 pence each (Ordinary Shares) through HSBC Bank PLC:   +-----------------------------------------------+-------------+|Date of purchase:  |22 March 2024|+-------------------------------------------

Aker Carbon Capture and CO280 form strategic alliance to develop carbon removal projects in the pulp and paper industry

Aker Carbon Capture and CO280 Solutions, have signed a Memorandum of Understanding (MoU) to collaborate on the development of large-scale Carbon Dioxide Removal (CDR) projects beginning in the US and Canada pulp and paper industry that will deliver permanent, verifiable, affordable carbon removals.The parties will collaborate as preferred partners on a project-by-project basis, for point source carbon capture plants for pulp and paper mills, with the ambition to deploy Aker Carbon Capture’s modularized Just Catch series. Both parties will be working toward a standard CDR solution, which

Ultomiris approved in the US for NMOSD

25 March 2024 Ultomiris approved in the US for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD) First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+ NMOSD the potential to live relapse-free Unprecedented relapse risk reduction observed in CHAMPION-NMOSD trial underscores how Ultomiris may redefine patient journey for rare neurological disease Ultomiris (ravulizumab-cwvz) has been approved in the United States (US) as the first and only long-acting C5 complement inhibitor for the treatment of adult patients with anti-

Invitation to presentation of Essity’s interim report for the first quarter 2024

The hygiene and health company Essity will publish its interim report for the first quarter of 2024 on April 25 at approximately 07:00 CET. President and CEO Magnus Groth and Executive Vice President and CFO Fredrik Rystedt will present the interim report at a live webcast and teleconference at 09:00 CET the same day.Link to the live webcast and teleconference, which can also be viewed afterwards: https://essity.videosync.fi/2024-04-25  Contact information for conference call with the possibility to ask questions:UK: +44 (0) 33 0551 02 00 USA: +1 786 697 35 01SWE: +46 (0)8 505 204

Notification of Catena’s 2024 Annual General Meeting

Shareholders of Catena AB (publ) are hereby invited to attend the Annual General Meeting on Thursday 25 April 2024 16:00 CEST, at Clarion Hotel Sea U, Kungsgatan 1, in Helsingborg, Sweden.25 March 2024, 08.00 a.m. CETA shareholder who wishes to participate in the Annual General Meeting must (i) be included as a shareholder in the share register maintained by Euroclear Sweden AB regarding the status on 17 April 2024, and (ii) notify the Company of their and eventual proxies intention to attend the Annual General Meeting on 19 April 2024 at latest via the Company webpage www.catena.se.

Can an athlete succeed on a plant-based diet?

Media release 25 March 2024 Härkis[®][ ]– the market leader brand of plant proteins in Finland – is the new collaboration partner of the Finnish Olympic team. The goal of this new collaboration is to encourage the sports community to try a plant-based diet while also debunking myths that are often associated with plant-based diets and sports. Sports Nutritionist Laura Manner from the Finnish Olympic Committee often receives questions about plant-based eating. One common question is whether plant-based food can provide an athlete with enough energy and proteins. Manner

JM Annual and Sustainability Report 2023

JM's Annual and Sustainability Report for the financial year 2023 is available as of today on the Group’s website.The Annual and Sustainability Report in Swedish is available in PDF format and in the European Single Electronic Format (ESEF) at www.jm.se . English translation is available in PDF format at www.jm.se/en .  As part of JM’s sustainability work, the Annual and Sustainability Report is available only in digital format.

ICA Gruppen publishes Green Bond Report

Solna 2024-03-25 ICA Gruppen completed its first green bond issue in May 2023 and is today publishing the first report on how the SEK 3.5 billion which the issue amounted to has been allocated – Green Bond Report 2024. The report shows how the financing of projects made possible through ICA Gruppen’s green bonds is estimated to have contributed to reduced emissions in excess of 16,997 tonnes CO\2 \in 2023.The funds from the issue have been used to finance projects within areas covered by ICA Gruppen’s Green Finance Framework: green buildings, renewable energy, clean transportation and

Transaction in Own Shares

    25 March 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |22/03/2024|+-------------------------------------------------------------

Veidekke: Annual and sustainability report 2023

Veidekke’s annual and sustainability report for 2023 was published today. In a challenging market, the company boosted its revenue, secured a strong order book and improved its underlying profit for the year. The board of directors has proposed to distribute the entire annual profits of NOK 7.9 per share in dividends to shareholders.“Dealing with all kinds of market conditions, including more demanding scenarios, is at the core of Veidekke. In the past year we again demonstrated our ability to adapt to changing circumstances and find solutions which enable us to fulfil our promises to both

Notice of Annual General Meeting of the shareholders in Intrum AB (publ)

The shareholders of Intrum AB (publ) are hereby summoned to the Annual General Meeting on Wednesday 24 April 2024, 14.00, at Grev Turegatan 30 (GT30), Stockholm. Registration for the meeting starts at 13.00.This document is an unofficial translation of the corresponding Swedish document. In the event of any discrepancies between this document and the Swedish version, the latter shall prevail. Right to attendShareholders who wish to attend the Annual General Meeting shall both            be entered in the company’s register of shareholders kept by Euroclear Sweden AB (not nominee-

Qlife signs letter of intent with South Korean company Precision Biosensor as part of B2B strategy to enter major markets with Egoo Health, through hospital@home partnerships

Qlife is pleased to announce that it has signed a Letter of Intent (LOI) with leading South Korean company Precision Biosensor, to introduce Egoo Health to the South Korean market. Qlife anticipates finalizing a comprehensive collaboration agreement over the next months. The LOI The agreement is focused on two distinct phases: · Regulatory Approvals: Precision Biosensor will navigate the regulatory landscape to secure product registration from the Korean Ministry of Food and Drug Safety (MFDS) for Egoo Health. · Commercialization in South Korea: Following registrations,

Africa Oil Announces Results of Share Buyback Program

VANCOUVER, BC, March 25, 2024 /CNW/ - (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“Africa Oil”, or the “Company”) is pleased to announce that the Company repurchased a total of 1,213,100 Africa Oil common shares during the period of March 18, 2024 to March 22, 2024 under the previously announced share buyback program. The launch of Africa Oil’s normal course issuer bid (share buyback) program, announced by the Company on December 4, 2023, is being implemented in accordance with the Market Abuse Regulation (EU) No 596/2014 (MAR) and Commission Delegated Regulation (EU) No 2016/

Sobi announces positive results from phase 3 study of Doptelet® for treatment of children and adolescents with ITP

· The primary endpoint was met, confirming the efficacy and safety of avatrombopag (Doptelet®) in treating children and adolescents with ITP · avatrombopag is widely approved for the treatment of adults with ITP; AVA-PED-301 data will support global regulatory filings to expand to children and adolescents with ITPSobi® today announced positive results from the AVA-PED-301 study (NCT04516967 ), evaluating the efficacy and safety of avatrombopag (Doptelet) for the treatment of

Polaris Private Equity and a consortium of existing shareholders announce a recommended public offer of SEK 132 in cash per share to the shareholders of Awardit

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States of America (the “US”), or any other jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law or

There are no items matching the current filter
There are no more items matching the current filter
Back to top